Perspective Study on How Can the Incentive Integrated E-IBD Chronic Disease Management Model Improve the Quality of Life in IBD Patients
Study Details
Study Description
Brief Summary
This study aims to prospectively explore the effect of incentive-integrated E-IBD (electronic inflammatory bowel disease) chronic disease management model on the improvement of IBD quality of life, and provide a more effective chronic disease management model for improving the quality of life and social participation of IBD patients.We firstly identify the IBD patients in need of empowerment disease activities through the questionnaire .Then, we feedback the patients' education content according to their needs found.Based on the social support network of patient organization and the medical support network of tertiary medical institutions, we complete the empowerment process of IBD patients' self-management initiative and self-management ability, through the internet. Finally ,we evaluate the quality of life(QoL), social participation,disease self-management level via questionnaire . Our primary outcome is the improvement of QoL score after three months' intervention.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Routine follow-up group
|
|
Experimental: IBD Disease Management Research Group
|
Other: education ,psycological support and social support
we would give targeted-education according to our patients' need(reflected via questionnaire; we would provide psycological and social support to patients based on their need reflected by questionnaire
|
Outcome Measures
Primary Outcome Measures
- QoL improvement after three months [three months]
Improvement score of quality of life after intervention for three months
Secondary Outcome Measures
- Socially activity limited rating [three months,one year]
Improvement score of socially activity limited rating after intervention for three months, or one year.
- HADS [three months,one year]
improvement score of anxiety or depression via HADS-A/D after intervention for three months, or one year.
- disease kownledge [three months,one year]
improvement of disease kownledge via CCKOWN after intervention for three months, or one year.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
1.Clinically diagnosed IBD patients,according to the criteria of the Inflammatory Bowel Group of the Gastroenterology Branch of the Chinese Medical Association in 2018;
-
2.Aged 18 to 75 years old;
-
3.Understand and comply with the requirements of the program and sign informed consent.
-
4.Identified as need intervention according to the patient identification questionnaire screening;
-
5.Patients with the ability to complete all course training and/or follow-up work;
-
6.Enrolled at least one year ahead of end of this study(for garantee of enough folllow-up time).
Exclusion Criteria:
-
1.Unable or unwilling to sign the consent form, or unable to follow the research procedure;
-
2.Patients who have had a stoma or ileorectal anastomosis (partial scales are not available);
-
3.Patients who do not complete training on time or do not complete follow-up assessments in their entirety;
-
4.Patients with other malignancies or life-threatening complications;
-
5.Pregnancy or lactation;
-
6.Patients whose remaining follow-up time less than one year before the end of this study.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine, Zhejiang University | Hangzhou | China | 310009 | |
2 | Department of Gastroenterology, Huzhou Central Hospital | Huzhou | China | ||
3 | Department of Gastroenterology, Ruijin Hospital | Shanghai | China | ||
4 | Department of Gastroenterology, Shaoxing Central Hospital | Shaoxing | China |
Sponsors and Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang University
Investigators
- Study Chair: Yan chen, Second Affiliated Hospital, School of Medicine, Zhejiang University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20230049